Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Feb 2019
Historique:
received: 17 01 2019
revised: 31 01 2019
accepted: 01 02 2019
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 25 6 2019
Statut: epublish

Résumé

The outcome of host-virus interactions is determined by a number of factors, some related to the virus, others to the host, such as environmental factors and genetic factors. Therefore, different individuals vary in their relative susceptibility to infections. Human cytomegalovirus (HCMV) is an important pathogen from a clinical point of view, as it causes significant morbidity and mortality in immunosuppressed or immunosenescent individuals, such as the transplanted patients and the elderly, respectively. It is, therefore, important to understand the mechanisms of virus infection control. In this review, we discuss recent advances in the immunobiology of HCMV-host interactions, with particular emphasis on the immunogenetic aspects (human leukocyte antigens, HLA; killer cell immunoglobulin-like receptors, KIRs; immunoglobulin genetic markers, GM allotypes) to elucidate the mechanisms underlying the complex host-virus interaction that determine various outcomes of HCMV infection. The results, which show the role of humoral and cellular immunity in the control of infection by HCMV, would be valuable in directing efforts to reduce HCMV spurred health complications in the transplanted patients and in the elderly, including immunosenescence. In addition, concerning GM allotypes, it is intriguing that, in a Southern Italian population, alleles associated with the risk of developing HCMV symptomatic infection are negatively associated with longevity.

Identifiants

pubmed: 30764515
pii: ijms20030685
doi: 10.3390/ijms20030685
pmc: PMC6386818
pii:
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN

Références

Genetics. 1999 Sep;153(1):1-3
pubmed: 10471694
Hum Immunol. 2000 Sep;61(9):942-9
pubmed: 11053639
Mech Ageing Dev. 2001 Apr 30;122(5):445-62
pubmed: 11292511
J Immunol. 2002 Jul 1;169(1):239-47
pubmed: 12077250
J Clin Virol. 2002 Aug;25 Suppl 2:S123-36
pubmed: 12361763
Transplantation. 1992 Nov;54(5):871-4
pubmed: 1332224
Clin Infect Dis. 2003 Dec 15;37(12):1603-6
pubmed: 14689339
Blood. 2004 Mar 1;103(5):1965-6
pubmed: 14976061
Lancet Infect Dis. 2004 Dec;4(12):725-38
pubmed: 15567122
Blood. 2006 Feb 1;107(3):1230-2
pubmed: 16239436
Lancet Infect Dis. 2006 Oct;6(10):653-63
pubmed: 17008174
J Infect Dis. 2007 Nov 1;196(9):1273-5
pubmed: 17922387
Am J Transplant. 2008 Jun;8(6):1312-7
pubmed: 18444913
Am J Transplant. 2008 Dec;8(12):2674-83
pubmed: 19032228
Virol J. 2009 Jan 09;6:4
pubmed: 19134204
Biol Blood Marrow Transplant. 2009 Mar;15(3):315-25
pubmed: 19203722
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
Science. 2010 Sep 3;329(5996):1148
pubmed: 20813938
N Engl J Med. 2010 Nov 18;363(21):2076-7; author reply 2077
pubmed: 21083406
Tissue Antigens. 2011 Mar;77(3):187-92
pubmed: 21299522
Arch Virol. 2011 May;156(5):907-10
pubmed: 21311920
Genes Immun. 2012 Feb;13(2):184-90
pubmed: 21993531
Nat Immunol. 2011 Dec 16;13(1):21-8
pubmed: 22179281
Curr Opin Immunol. 2012 Aug;24(4):507-11
pubmed: 22541724
Methods Mol Biol. 2012;882:635-80
pubmed: 22665258
Int J Immunogenet. 2013 Feb;40(1):77-81
pubmed: 23302099
Future Virol. 2012 Mar 1;7(3):279-293
pubmed: 23308079
Immun Ageing. 2013 Aug 13;10(1):33
pubmed: 23938060
Clin Immunol. 2013 Dec;149(3):475-86
pubmed: 24239836
J Infect Dis. 2014 Oct 1;210(7):1083-9
pubmed: 24737799
J Infect Dis. 2014 Dec 1;210(11):1823-6
pubmed: 24973460
Gene Geogr. 1989 Aug-Dec;3(2-3):141-64
pubmed: 2518843
J Pathol. 2015 Jan;235(2):288-97
pubmed: 25205255
Acta Haematol. 2015;133(2):162-3
pubmed: 25278006
Semin Immunopathol. 2014 Nov;36(6):627-40
pubmed: 25288477
Cancer Immunol Res. 2015 Jun;3(6):575-82
pubmed: 26041808
Hum Immunol. 2015 Aug;76(8):591-4
pubmed: 26382248
Immun Ageing. 2016 Jan 05;13:1
pubmed: 26734066
Nephrourol Mon. 2015 Nov 29;7(6):e31635
pubmed: 26866009
Medicine (Baltimore). 2016 Feb;95(6):e2735
pubmed: 26871815
Cell Immunol. 2017 Feb;312:67-70
pubmed: 27825564
Front Immunol. 2017 Mar 02;8:195
pubmed: 28303136
Geroscience. 2017 Jun;39(3):245-249
pubmed: 28624867
Geroscience. 2017 Jun;39(3):293-303
pubmed: 28647907
Geroscience. 2017 Jun;39(3):273-291
pubmed: 28647908
Immun Ageing. 2017 Jun 26;14:16
pubmed: 28670328
Immunology. 2018 Apr;153(4):523-531
pubmed: 29067686
Immun Ageing. 2018 Mar 2;15:11
pubmed: 29507595
HLA. 2018 Sep;92(3):137-143
pubmed: 29877054
Immun Ageing. 2018 Jul 2;15:15
pubmed: 29988679
Curr Pharm Des. 2018;24(26):3113-3122
pubmed: 30205795
Hum Immunol. 2018 Dec;79(12):825-833
pubmed: 30321631
Immun Ageing. 2018 Nov 6;15:25
pubmed: 30450118
Immun Ageing. 2018 Nov 6;15:26
pubmed: 30450119
Immunogenetics. 1987;26(4-5):216-9
pubmed: 3653939
J Immunogenet. 1979 Aug;6(4):271-87
pubmed: 521665
Transpl Int. 1994 Aug;7(5):362-7
pubmed: 7993574
Lancet. 1993 Feb 20;341(8843):494-5
pubmed: 8094513

Auteurs

Anna Aiello (A)

Sezione di Patologia Generale, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. anna.aiello@unipa.it.

Giulia Accardi (G)

Sezione di Patologia Generale, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. giulia.accardi@unipa.it.

Giuseppina Candore (G)

Sezione di Patologia Generale, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. giuseppina.candore@unipa.it.

Calogero Caruso (C)

Sezione di Patologia Generale, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. calogero.caruso@unipa.it.

Claudia Colomba (C)

Dipartimento di Scienze per la Promozione della Salute e Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", Università di Palermo, Via del Vespro 129, 90127 Palermo, Italy. claudia.colomba@unipa.it.

Danilo Di Bona (D)

Dipartimento dell'Emergenza e dei Trapianti d'Organo, Università di Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy. danilo.dibona@uniba.it.

Giovanni Duro (G)

Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Via Ugo La Malfa 153, 90146 Palermo, Italy. giovanni.duro@ibim.cnr.it.

Caterina Maria Gambino (CM)

Sezione di Patologia Generale, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. caterinamaria.gambino@unipa.it.

Mattia Emanuela Ligotti (ME)

Sezione di Patologia Generale, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy. mattiaemanuela.ligotti@unipa.it.

Janardan P Pandey (JP)

Department of Microbiology and Immunology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA. pandeyj@musc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH